androcur 50 mg tabletter
orifarm a/s - cyproteronacetat - tabletter - 50 mg
androcur 50 mg tabletter
2care4 aps - cyproteronacetat - tabletter - 50 mg
androcur 50 mg tabletter
europharma.dk aps - cyproteronacetat - tabletter - 50 mg
androcur depot 100 mg/ml injektionsvæske, opløsning
bayer ab - cyproteronacetat - injektionsvæske, opløsning - 100 mg/ml
abiraterone mylan
mylan ireland limited - abiraterone acetat - prostatiske neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone accord
accord healthcare s.l.u. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasmer, kastration-resistent - antineoplastiske midler - treatment of adult patients with prostate cancer.
feminil mite 2,0+0,035 mg overtrukne tabletter
sandoz a/s - cyproteronacetat, ethinylestradiol - overtrukne tabletter - 2,0+0,035 mg
zyrona 2,0+0,035 mg overtrukne tabletter
orifarm generics a/s - cyproteronacetat, ethinylestradiol - overtrukne tabletter - 2,0+0,035 mg